Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for Male Infertility
NCT02061384Phase 2Completed
- Sponsor
- University of Washington
- Start
- Aug 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of isotretinoin in oligoasthenoteratozoospermia (OATS) (2 arms), sponsored by University of Washington. Primary endpoint: Millions of Sperm Per Ejaculate at 20 weeks. Started Aug 2014; status: completed.
02
Drugs
isotretinoin
03
Conditions
oligoasthenoteratozoospermia (OATS)
Beyond the preview
Go deeper on NCT02061384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061384.